Stock Market News

Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk

wcc wcc
May 07, 2026 - 19:06
0 1
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk
New generics in Canada likely mark the start of a decline in international revenue of semaglutide, the active ingredient in Novo's Ozempic and Wegovy.

Previous Article

Software stocks stage a comeback. Plus, why Boeing's CEO going to China matters

Next Article

While many international brands retreat, McDonald’s is supersizing its China ...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0
wcc
wcc

Related Posts

T-Mobile US (TMUS) Lagged on Emerging Network Competition Concerns

T-Mobile US (TMUS) Lagged on Emerging Network Compet...

wcc
Jul 28, 2026
0
1
Chevron Corporation (CVX) Remains Well Placed to Benefit From High Commodity Prices

Chevron Corporation (CVX) Remains Well Placed to Ben...

wcc
Jul 28, 2026
0
0
AT&T (T) Remains Competitive Despite Satellite Connectivity Concerns

AT&T (T) Remains Competitive Despite Satellite Conne...

wcc
Jul 28, 2026
0
1
US goods trade deficit contracts, still expected to subtract from Q2 GDP growth

US goods trade deficit contracts, still expected to ...

wcc
Jul 28, 2026
0
1
Coca-Cola second quarter earnings top estimates, raises full-year guidance

Coca-Cola second quarter earnings top estimates, rai...

wcc
Jul 28, 2026
0
1

Lawmakers renew push to axe a lucrative tax loophole...

wcc
Jul 28, 2026
0
1

Comments (0)

User